RG3 (Rhodiola) vs Semax
Overview
RG3 (Rhodiola) and Semax are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares RG3 (Rhodiola) and Semax across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| RG3 (Rhodiola) | Semax | |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | 3-6 mg | 300-600 mcg |
| Frequency | daily | daily |
| Reported benefits | Stress reduction, cognitive enhancement, energy | Enhanced focus and memory, neuroprotection, improved learning, mood enhancement, stress resilience |
| Reported side effects | Well-tolerated | Generally safe. Possible: overstimulation, sleep disturbances if taken late |
Key differences
Primary use. RG3 (Rhodiola) is categorised under Cognitive Enhancement, while Semax falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. RG3 (Rhodiola): not FDA-approved; treated as a research compound. Semax: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. RG3 (Rhodiola) is typically dosed at 3-6 mg (daily). Semax is typically dosed at 300-600 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking RG3 (Rhodiola) and Semax has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between RG3 (Rhodiola) and Semax?
- RG3 (Rhodiola) and Semax are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. RG3 (Rhodiola) is not FDA-approved; generally classified as a research compound, whereas Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is RG3 (Rhodiola) used for?
- Adaptogenic peptide.
- What is Semax used for?
- Cognitive enhancement, focus, memory.
- Can you take RG3 (Rhodiola) and Semax together?
- Some users combine peptides within a single protocol, but stacking RG3 (Rhodiola) and Semax has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is RG3 (Rhodiola) or Semax FDA-approved?
- RG3 (Rhodiola) is not FDA-approved; generally classified as a research compound. Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- RG3 (Rhodiola) — full monograph: mechanism, research, dosing & references
- Semax — full monograph: mechanism, research, dosing & references